Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Raloxifene | Raloxifene (Keoxifene) is a benzothiophene-derived selective estrogen receptor modulator (SERM). Raloxifene has estrogen-agonistic effects on bone and lipids and estrogen-antagonistic effects on the breast and uterus. Raloxifene is used for breast cancer and osteoporosis research [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Keoxifene; LY156758 free base; LY139481. CAS No. 84449-90-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg. Product ID: HY-13738. |  |
| Raloxifene-4',6-Diglucuronide Lithium Salt | A metabolite of Raloxifene.Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Grades: > 95%. Molecular formula: C40H41NO16S. 2 Li. Mole weight: 837.71. |  |
| Raloxifene 4,6-glucuronide | Raloxifene 4,6-glucuronide. Uses: For analytical and research use. Group: Impurity standards. CAS No. 182507-20-6. Molecular Formula: C40H43NO16S. Mole Weight: 825.84. Catalog: APB182507206. |  |
| Raloxifene 4-β-D-Glucuronide Lithium Salt | | |
| Raloxifene 4-D-glucuronide D4 | Raloxifene 4-D-glucuronide D4 is a formidable metabolite derived from Raloxifene, renowned for its usage in studying osteoporosis within postmenopausal women. Molecular formula: C34H31NO10SD4. Mole weight: 653.73. | |
| Raloxifene-4-D-glucuronide D4 lithium salt | Raloxifene-4-D-glucuronide D4 lithium salt is a notable biomedical compound, aiding in studying postmenopausal osteoporosand breast cancer. Operating as a discerning estrogen receptor modulator, this stable derivative of Raloxifene showcases enhanced solubility and bioavailability conferred by its salt form. Molecular formula: C34H30NO10SD4 Li. Mole weight: 659.66. | |
| Raloxifene-4-D-glucuronide lithium salt | Raloxifene-4-D-glucuronide lithium salt is an esteemed biomedical compound, ingeniously deployed for studying the ravages of osteoporosand curbing the sinister growth of breast cancer. This prodigious innovation is a cleverly modified iteration of raloxifene, an acclaimed selective estrogen receptor modulator (SERM). Molecular formula: C34H34NO10S Li. Mole weight: 655.64. | |
| Raloxifene-4'-D-glucuronide lithium salt | Raloxifene-4'-D-glucuronide lithium salt is a biomedical product used in the research of osteoporosand breast cancer. This compound, containing Raloxifene and lithium, has potential estrogen agonist/antagonist activity, enabling it to selectively modulate estrogen receptors. Its glucuronide form enhances its solubility and bioavailability. Synonyms: Raloxifene 4'-Glucuronide; 182507-22-8; Raloxifene-4-glucuronide; UNII-UZ95WFT3LZ; UZ95WFT3LZ; (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-[6-hydroxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]phenoxy]oxane-2-carboxylic acid; beta-D-Glucopyranosiduronic acid, 4- (6-hydroxy-3- (4- (2- (1-piperidinyl)ethoxy)benzoyl)benzo (b)thien-2-yl)phenyl; beta-D-Glucopyranosiduronic acid, 4-[6-hydroxy-3-[4-[2- (1-piperidinyl) ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl; CHEMBL176790; DTXSID601312492; AKOS040736548; Raloxifene-4'-D-glucuronide lithium salt; HY-135582; CS-0113549; Q27291346; (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-(6-hydroxy-3-(4-(2-(piperidin-1-yl)ethoxy)benzoyl)benzo[b]thiophen-2-yl)phenoxy)tetrahydro-2H-pyran-2-carboxylic acid.BETA.-D-GLUCOPYRANOSIDURONIC ACID, 4- (6-HYDROXY-3- (4- (2- (1-PIPERIDINYL)ETHOXY)BENZOYL)BENZO (B)THIEN-2-YL)PHENYL. Molecular formula: C34H35NO10S·xLi. Mole weight: 649.71 (free acid). | |
| Raloxifene-4' -glucuronide | A metabolite of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 4-[6-Hydroxy-3-[4-2[2- (1-piperindinyl) ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl-b-D-glucopyranosiduronic acid. Grades: > 95%. CAS No. 182507-22-8. Molecular formula: C34H35NO10S. Mole weight: 649.71. | |
| Raloxifene 4-Monomethyl Ether | Raloxifene 4-Monomethyl Ether. Group: Biochemicals. Alternative Names: [6-Hydroxy-2- (4-methoxyphenyl) benzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone. Grades: Highly Purified. CAS No. 185415-07-0. Pack Sizes: 10mg. Molecular Formula: C29H29NO4S, Molecular Weight: 487.61. US Biological Life Sciences. |  Worldwide |
| Raloxifene 6,4-bis-b-D-glucuronide | Raloxifene 6,4-bis-b-D-glucuronide, an enticing biomedical entity, manifests promising potential as a therapeutic agent targeting an array of ailments. Derived from Raloxifene, a selective estrogen receptor modulator (SERM), it serves as a glucuronide metabolite with a primary focus on tackling postmenopausal osteoporosis. Its remarkable aptitude in impeding bone resorption and preserving bone density renders it an efficacious choice in the management of osteoporosis-linked afflictions. Synonyms: (3R,4R,5R,6R)-6-[4-[6-[(2S,3S,4S,5S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid; Raloxifene 6,4'-Bis-beta-D-glucuronide; AKOS030241639; Raloxifene 6,4'-Bis- beta -D-glucuronide. CAS No. 182507-20-6. Molecular formula: C40H43NO16S. Mole weight: 825.85. | |
| Raloxifene 6-D-glucuronide | Raloxifene 6-D-glucuronide is a formidable and discriminative estrogen receptor modulator (SERM), aiding in unraveling the intricate labyrinth of Raloxifene's metabolic pathways and elimination mechanisms. Synonyms: 2- (4-Hydroxyphenyl) -3-[4-2[2- (1-piperindinyl) ethoxybenzoyl]benzo[b]thien-6-yl]-b-D-glucopyranosiduronic acid. Molecular formula: C34H35NO10S. Mole weight: 649.71. | |
| Raloxifene 6-D-glucuronide D4 | Raloxifene 6-D-glucuronide D4 is a pharmacological compound for studying osteoporosand breast carcinoma acting as an estrogen receptor modifier. Molecular formula: C34H31NO10SD4. Mole weight: 653.73. | |
| Raloxifene-6-D-glucuronide D4 lithium salt | Raloxifene-6-D-glucuronide D4 lithium salt is a vital pharmaceutical compound extensively employed in the biomedical sector with application revolving around the research of osteoporosis in postmenopausal females. This compound functions as an extraordinary selective estrogen receptor modulator. Molecular formula: C34H30NO10SD4 Li. Mole weight: 659.66. | |
| Raloxifene-6-D-glucuronide lithium salt | Raloxifene-6-D-glucuronide lithium salt is a biomedical compound, used for studying the scourge of osteoporosand hormone receptor-positive breast cancer. It is perched as a lithium salt derivative of Raloxifene-6-D-glucuronide. Molecular formula: C34H34NO10S Li. Mole weight: 655.64. | |
| Raloxifene 6'-glucuronide | Raloxifene 6'-glucuronide. Uses: For analytical and research use. Group: Impurity standards. CAS No. 174264-50-7. Molecular Formula: C34H35NO10S. Mole Weight: 649.71. Catalog: APB174264507. | |
| Raloxifene-6-glucuronide | A metabolite of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2- (4-Hydroxyphenyl) -3-[4-[2- (1-piperidinyl) ethoxybenzoyl]benzo[b]thien-6-yl]-β -D-glucopyranosiduronic Acid. Grades: > 95%. CAS No. 174264-50-7. Molecular formula: C34H35NO10S. Mole weight: 649.72. | |
| Raloxifene-6-Glucuronide Lithium Salt | A metabolite of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2- (4-Hydroxyphenyl) -3-[4-[2- (1-piperidinyl) ethoxybenzoyl]benzo[b]thien-6-yl]-β -D-glucopyranosiduronic Acid Lithium Salt. Grades: > 95%. Molecular formula: C34H34LiNO10S. Mole weight: 655.64. | |
| Raloxifene 6-Monomethyl Ether | Raloxifene 6-Monomethyl Ether. Group: Biochemicals. Alternative Names: [2- (4-Hydroxyphenyl) -6-methoxybenzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone. Grades: Highly Purified. CAS No. 178451-13-3. Pack Sizes: 10mg. Molecular Formula: C29H29NO4S, Molecular Weight: 487.61. US Biological Life Sciences. | Worldwide |
| Raloxifene Bismethyl Ether | An intermediate in the synthesis of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Raloxifene d4 | Heterocyclic Organic Compound. Alternative Names: RALOXIFENE-D4. CAS No. 1185076-44-1. Molecular formula: C28H23D4NO4S. Mole weight: 477.607927112. Appearance: Yellow to Orange Solid. Catalog: ACM1185076441. |  |
| Raloxifene-d4 | Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 4-Glucuronide (4- [6-Hydroxy-3- [4- [2- (1-piperidinyl) ethoxy-d4]benzoyl]benzo [b]thien-2-yl]phenyl-ß-D-glucopyranosiduronic acid) | A labeled metabolite of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Alternative Names: 4- [6-Hydroxy-3- [4- [2- (1-piperidinyl) ethoxy-d4]benzoyl]benzo [b]thien-2-yl]phenyl-ß-D-glucopyranosiduronic acid. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 6,4-Bis(2,3,4,6-tetra-O-acetyl- β-D-glucuronide Methyl Ester) | An intermediate in the production of labeled Raloxifene metabolites. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 6,4-Bis- β-D-glucuronide | A labeled metabolite of Raloxifene. Group: Biochemicals. Alternative Names: 2-[4-( β -D-Glucopyranuronosyloxy) phenyl]-3- [4- [2- (1-piperidinyl) ethoxy-d4]benzoyl]benzo [b]thien-6-yl β-D-Glucopyranosiduronic Acid. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 6-Glucuronide (2-(4-Hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy-d4-benzoyl]benzo[b]thien-6-yl]-ß-D-glucopyranosiduronic acid) | A labeled metabolite of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Alternative Names: 2-(4-Hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy-d4-benzoyl]benzo[b]thien-6-yl]-ß-D-glucopyranosiduronic acid. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 bismethyl ether | Heterocyclic Organic Compound. Alternative Names: 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone-d4; [6-Methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone-d4. CAS No. 1185006-58-9. Molecular formula: C30H27D4NO4S. Mole weight: 505.66. Appearance: Yellow Foam. Purity: 0.96. IUPACName: [6-methoxy-2-(4-methoxyphenyl)-1-benzothiophen-3-yl]-[4-(1,1,2,2-tetradeuterio-2-piperidin-1-ylethoxy)phenyl]methanone. Catalog: ACM1185006589. | |
| Raloxifene-d4 Bismethyl Ether | An intermediate in the synthesis of deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4, Hydrochloride | Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene Dimer Impurity | Raloxifene Dimer Impurity. Uses: For analytical and research use. Group: Impurity standards. CAS No. 618902-12-8. Molecular Formula: C56H52N2O8S2. Mole Weight: 945.16. Catalog: APB618902128. | |
| Raloxifene Dimethoxy Impurity | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Grades: > 95%. Molecular formula: C30H31NO4S. Mole weight: 501.65. | |
| Raloxifene EP Impurity A, N-oxide | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Grades: > 95%. Molecular formula: C42H44N2O8S. Mole weight: 736.89. | |
| Raloxifene EP IMpurity B | Raloxifene EP IMpurity B. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1391054-73-1. Molecular Formula: C28H27NO4S. Mole Weight: 473.59. Catalog: APB1391054731. | |
| Raloxifene EP IMpurity C | Raloxifene EP IMpurity C. Uses: For analytical and research use. Group: Impurity standards. CAS No. 195454-31-0. Molecular Formula: C28H27NO5S. Mole Weight: 489.59. Catalog: APB195454310. | |
| Raloxifene EP IMpurity D | Raloxifene EP IMpurity D. Uses: For analytical and research use. Group: Impurity standards. CAS No. 177744-96-6. Molecular Formula: C21H14O4S. Mole Weight: 362.4. Catalog: APB177744966. | |
| Raloxifene EP IMpurity E | Raloxifene EP IMpurity E. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1700655-64-6. Molecular Formula: C28H27NO4S. Mole Weight: 473.59. Catalog: APB1700655646. | |
| Raloxifene hydrochloride | Raloxifene hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 82640-04-8. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Raloxifene hydrochloride | Raloxifene hydrochloride (Keoxifene hydrochloride) is a second generation selective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue [1]. Uses: Scientific research. Group: Natural products. Alternative Names: Keoxifene hydrochloride; LY156758; LY139481 hydrochloride. CAS No. 82640-04-8. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg. Product ID: HY-13738A. | |
| Raloxifene hydrochloride | Raloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used for prevention of osteoporosis in postmenopausal women. Uses: Prevention of osteoporosis in postmenopausal women. Synonyms: PD 0332991 isethionate; PD0332991 isethionate; PD-0332991 isethionate; Evista; Raloxifene Hcl; Keoxifene hydrochloride; (6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride. Grades: >98%. CAS No. 82640-04-8. Molecular formula: C28H28ClNO4S. Mole weight: 510.04. | |
| Raloxifene, Hydrochloride ( [6-Hydroxy-2- (4-hydroxyphenyl) -benzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone, Keoxifene, LY-139481) | A nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Alternative Names: [6-Hydroxy-2- (4-hydroxyphenyl) -benzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone, Keoxifene, LY-139481. Grades: Highly Purified. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Raloxifene (hydrochloride) (Standard) | Raloxifene (hydrochloride) (Standard) is the analytical standard of Raloxifene (hydrochloride). This product is intended for research and analytical applications. Raloxifene hydrochloride (Keoxifene hydrochloride) is a second generation selective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue [1]. Uses: Scientific research. Group: Natural products. Alternative Names: Keoxifene (hydrochloride)(Standard); LY156758(Standard); LY139481 (hydrochloride) (Standard). CAS No. 82640-04-8. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13738AR. | |
| Raloxifene Impurity 1 | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: [6-[ (Methylsulfonyl) oxy]-2-[4-[ (methylsulfonyl) oxy]phenyl]benzo[b]thien-3-yl][4-[2- (1-piperidinyl) ethoxy]phenyl]methanone Hydrochloride;Raloxifene Dimesylate Hydrochloride. Grades: > 95%. CAS No. 84449-85-4. Molecular formula: C30H31NO8S3. HCl. Mole weight: 666.24. | |
| Raloxifene Impurity 1 | Raloxifene Impurity 1. Uses: For analytical and research use. Group: Impurity standards. CAS No. 84449-85-4. Molecular Formula: C30H32ClNO8S3. Mole Weight: 666.21. Catalog: APB84449854. | |
| Raloxifene Impurity 11 | Raloxifene Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1677681-02-5. Molecular Formula: C18H22N2O4S. Mole Weight: 362.44. Catalog: APB1677681025. | |
| Raloxifene Impurity 12 | Raloxifene Impurity 12. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2632-13-5. Molecular Formula: C9H9BrO2. Mole Weight: 229.07. Catalog: APB2632135. | |
| Raloxifene Impurity 13 | Raloxifene Impurity 13. Uses: For analytical and research use. Group: Impurity standards. CAS No. 63675-74-1. Molecular Formula: C16H14O2S. Mole Weight: 270.35. Catalog: APB63675741. | |
| Raloxifene Impurity 15 | Raloxifene Impurity 15. Uses: For analytical and research use. Group: Impurity standards. CAS No. 225648-21-5. Molecular Formula: C15H12O2S. Mole Weight: 256.32. Catalog: APB225648215. | |
| Raloxifene Impurity 18 | Raloxifene Impurity 18. Uses: For analytical and research use. Group: Impurity standards. CAS No. 414861-41-9. Molecular Formula: C14H10O3S. Mole Weight: 258.29. Catalog: APB414861419. | |
| Raloxifene Impurity 19 | Raloxifene Impurity 19. Uses: For analytical and research use. Group: Impurity standards. CAS No. 937666-17-6. Molecular Formula: C14H19NO3. Mole Weight: 249.31. Catalog: APB937666176. | |
| Raloxifene Impurity 2 | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2-(4-Hydroxyphenyl)benzothiophene-6-ol. Grades: > 95%. CAS No. 63676-22-2. Molecular formula: C14H10O2S. Mole weight: 242.3. | |
| Raloxifene Impurity 20 | Raloxifene Impurity 20. Uses: For analytical and research use. Group: Impurity standards. CAS No. 767286-87-3. Molecular Formula: C15H21NO3. Mole Weight: 263.34. Catalog: APB767286873. | |
| Raloxifene Impurity 21 | Raloxifene Impurity 21. Uses: For analytical and research use. Group: Impurity standards. CAS No. 938140-30-8. Molecular Formula: C13H17NO3. Mole Weight: 235.28. Catalog: APB938140308. | |
| Raloxifene Impurity 3 | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2-[4-[ (Methylsulfonyl) oxy]phenyl]benzo[b]thien-6-yl methanesulfonate; 2-[4-[(Methylsulfonyl)oxy]phenyl]-benzo[b]thiophene-6-ol Methanesulfonate; Raloxifene Impurity; 2-(4-Hydroxyphenyl)benzo[b]thiophen-6-ol Bimesylate. Grades: > 95%. CAS No. 84449-65-0. Molecular formula: C16H14O6S3. Mole weight: 398.48. | |
| Raloxifene Impurity 4 | Raloxifene Impurity 4. Uses: For analytical and research use. Group: Impurity standards. CAS No. 63676-22-2. Molecular Formula: C14H10O2S. Mole Weight: 242.29. Catalog: APB63676222. | |
| Raloxifene Impurity 5 | Raloxifene Impurity 5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 84449-80-9. Molecular Formula: C14H20ClNO3. Mole Weight: 285.77. Catalog: APB84449809. | |
| Raloxifene Impurity 6 | Raloxifene Impurity 6. Uses: For analytical and research use. Group: Impurity standards. CAS No. 89407-97-6. Molecular Formula: C15H21NO3. Mole Weight: 263.34. Catalog: APB89407976. | |
| Raloxifene Impurity 6 (2-Ethyl-1-Benzothiophene) | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2-Ethylbenzo[b]thiophene. Grades: > 95%. CAS No. 1196-81-2. Molecular formula: C10H10S. Mole weight: 162.26. | |
| Raloxifene Impurity 7 | Raloxifene Impurity 7. Uses: For analytical and research use. Group: Impurity standards. CAS No. 84449-65-0. Molecular Formula: C16H14O6S3. Mole Weight: 398.46. Catalog: APB84449650. | |
| Raloxifene Impurity B | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: [6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-7-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone; Raloxifene Impurity C; [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-7-yl](4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone;3-Des[4-(2-Piperidinyl)ethoxy]benzoyl-7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene. Grades: > 95%. CAS No. 1391054-73-1. Molecular formula: C28H27NO4S. Mole weight: 473.6. | |
| Raloxifene Impurity C | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-oxido-1-piperidinyl)ethoxy]phenyl]methanone; USP Raloxifene Related Compound C; Raloxifene EP Impurity C; Raloxifene N-Oxide. Grades: > 95%. CAS No. 195454-31-0. Molecular formula: C28H27NO5S. Mole weight: 489.58. | |
| Raloxifene impurity D | Raloxifene impurity D. Group: Biochemicals. Grades: Highly Purified. CAS No. 177744-96-6. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 250mg. Molecular Formula: C21H14O4S. US Biological Life Sciences. | Worldwide |
| Raloxifene Impurity D | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl](4-hydroxyphenyl)methanone; LY 88074. Grades: > 95%. CAS No. 177744-96-6. Molecular formula: C21H14O4S. Mole weight: 362.41. | |
| Raloxifene Impurity III | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Grades: > 95%. Molecular formula: C14H19NO3. HCl. Mole weight: 285.77. | |
| Raloxifene N-oxide | Raloxifene N-oxide. Group: Biochemicals. Alternative Names: [6-Hydroxy-2- (4-hydroxyphenyl) benzo [b] thien-3-yl] [4- [2- (1-oxido-1-piperidinyl) ethoxy] phenyl] methanone; Raloxifene impurity C. Grades: Highly Purified. CAS No. 195454-31-0. Pack Sizes: 500mg. Molecular Formula: C28H27NO5S. US Biological Life Sciences. | Worldwide |
| Raloxifene N-Oxide | Raloxifene N-Oxide. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Raloxifene Imp. C (EP), Raloxifene USP RC C, Raloxifene N-Oxide,Raloxifene Hydrochloride Imp. C (EP), Raloxifene USP Related Compound C, [6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl][4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide. CAS No. 195454-31-0. IUPAC Name: [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-[2-(1-oxidopiperidin-1-ium-1-yl)ethoxy]phenyl]methanone. Molecular Formula: C28H27NO5S. Mole Weight: 489.58. Catalog: APS195454310. SMILES: Oc1ccc (cc1)c2sc3cc (O)ccc3c2C (=O)c4ccc (OCC[N+]5 ([O-])CCCCC5)cc4. Format: Neat. | |
| 3-Des[4- (2-Piperidinyl) ethoxy]benzoyl-7-[4- (2-Piperidinyl) ethoxy]benzoyl Raloxifene | 3-Des[4- (2-Piperidinyl) ethoxy]benzoyl-7-[4- (2-Piperidinyl) ethoxy]benzoyl Raloxifene. Group: Biochemicals. Alternative Names: Raloxifene Impurity B. Grades: Highly Purified. CAS No. 1391054-73-1. Pack Sizes: 1mg, 2mg, 5mg, 10mg, 25mg. Molecular Formula: C28H27NO4S. US Biological Life Sciences. | Worldwide |
| 3-Des[4-(2-Piperidinyl)ethoxy]benzoyl-7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene | 3-Des[4-(2-Piperidinyl)ethoxy]benzoyl-7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-7-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, Raloxifene Hydrochloride Imp. B (EP), [6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothien-7-yl][4-(2-piperidin-1-yl)ethoxy]-phenyl]methanone. CAS No. 1391054-73-1. IUPAC Name: [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-7-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone. Molecular Formula: C28H27NO4S. Mole Weight: 473.58. Catalog: APS1391054731. SMILES: Oc1ccc (cc1)c2cc3ccc (O)c (C (=O)c4ccc (OCCN5CCCCC5)cc4)c3s2. Format: Neat. | |
| 4-Raloxifene-β-D-glucopyranoside | 4-Raloxifene-β-D-glucopyranoside. Uses: For analytical and research use. Group: Impurity standards. CAS No. 334758-19-9. Molecular Formula: C34H37NO9S. Mole Weight: 635.73. Catalog: APB334758199. | |
| 4'-tert-Butyldimethylsilyl-6-hydroxy raloxifene | 4'-tert-Butyldimethylsilyl-6-hydroxy raloxifene. Group: Biochemicals. Alternative Names: [2- [4- [ [ (1, 1-Dimethylethyl) dimethylsilyl] oxy] phenyl] -6-hydroxybenzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone. Grades: Highly Purified. CAS No. 174264-46-1. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C34H41NO4SSi. US Biological Life Sciences. | Worldwide |
| 4-tert-Butyldimethylsilyl-6-hydroxy Raloxifene-d4 | Labeled, protected Raloxifene. Group: Biochemicals. Alternative Names: [2- [4- [ [ (1, 1-Dimethylethyl) dimethylsilyl] oxy] phenyl] -6-hydroxybenzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone-d4. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
